These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23602298)

  • 1. New oral anticoagulants for stroke prevention in left ventricular hypertrabeculation/noncompaction?
    Stöllberger C; Finsterer J
    Int J Cardiol; 2013 Oct; 168(3):2910-1. PubMed ID: 23602298
    [No Abstract]   [Full Text] [Related]  

  • 2. A combination of left ventricular hypertrabeculation/noncompaction and muscular dystrophy in a stroke patient.
    Wang J; Zhu Q; Kong X; Hu B; Shi H; Liang B; Zhou M; Cao F
    Int J Cardiol; 2014 Jun; 174(2):e68-71. PubMed ID: 24774359
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary prophylactic anticoagulation is mandatory if noncompaction is associated with atrial fibrillation or heart failure.
    Finsterer J; Stöllberger C
    Int J Cardiol; 2015 Apr; 184():268-269. PubMed ID: 25746489
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequency of stroke and embolism in left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Blazek G; Dobias C; Hanafin A; Wegner C; Finsterer J
    Am J Cardiol; 2011 Oct; 108(7):1021-3. PubMed ID: 21784395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated left ventricular noncompaction causing stroke in a 30-year-old woman: case report and literature review.
    Baquero GA; Colegrove DJ; Banchs JE
    Tex Heart Inst J; 2013; 40(3):331-8. PubMed ID: 23914034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular noncompaction.
    Mangrolia N; Watson T; Gopalan D; Ray KK
    J Cardiovasc Med (Hagerstown); 2011 Jun; 12(6):430-3. PubMed ID: 21119528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHADS2- and CHA2DS2VASc scores and embolic risk in left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Wegner C; Finsterer J
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):709-12. PubMed ID: 22142779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant drugs in noncompaction: a mandatory therapy?
    Fazio G; Corrado G; Zachara E; Rapezzi C; Sulafa AK; Sutera L; Stollberger C; Sormani L; Finsterer J; Benatar A; Di Gesaro G; Visconti C; D'angelo L; Novo G; Mongiovi M; Cavusoglu Y; Baumhakel M; Drago F; Indovina G; Ferrara F; Carerj S; Pipitone S; Novo S
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1095-7. PubMed ID: 18852579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.
    Fernandez MM; von Schéele B; Hogue S; Kwong WJ
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiogram in left ventricular hypertrabeculation/noncompaction.
    Madias JE
    Am J Cardiol; 2012 Feb; 109(4):599; author reply 599. PubMed ID: 22293225
    [No Abstract]   [Full Text] [Related]  

  • 11. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
    Aguilar MI; Kuo RS; Freeman WD
    Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke and ventricular dysfunction in a patient with isolated left ventricular noncompaction.
    Nakajima M; Hirano T; Doi H; Uchino M
    Intern Med; 2007; 46(15):1251-4. PubMed ID: 17675779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poliomyelitis and left ventricular hypertrabeculation (noncompaction).
    Finsterer J; Stöllberger C
    Int J Cardiol; 2012 Jun; 158(1):e15-6. PubMed ID: 22078391
    [No Abstract]   [Full Text] [Related]  

  • 14. Noncompaction and embolic myocardial infarction: the importance of oral anticoagulation.
    Pulignano G; Tinti MD; Tolone S; Musto C; De Lio L; Pino PG; Minardi G; Violini R; Uguccioni M
    Rev Port Cardiol; 2015; 34(7-8):497.e1-4. PubMed ID: 26162290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cortical stroke secondary to an isolated left ventricular noncompaction in a 29-year-old female.
    Younan H; Alroughani R; Guindi R
    Indian Heart J; 2016 Sep; 68 Suppl 2(Suppl 2):S158-S160. PubMed ID: 27751274
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients].
    Reicke B; Masuhr F; Weih M
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):391-5. PubMed ID: 18604772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of neurological and cardiovascular disease in left ventricular hypertrabeculation/noncompaction.
    Pichlbauer E; Stöllberger C; Finsterer J
    Int J Cardiol; 2012 Dec; 162(1):e18-20. PubMed ID: 22658350
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticoagulation: stroke prevention in patients with atrial fibrillation.
    Waldo AL
    Cardiol Clin; 2009 Feb; 27(1):125-35, ix. PubMed ID: 19111769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation.
    Overvad TF; Larsen TB; Albertsen IE; Rasmussen LH; Lip GY
    Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1619-29. PubMed ID: 24215192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.